Zevra Therapeutics ZVRA
NASDAQ ZVRA
$12.40 -0.14 (-1.12%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zevra Therapeutics (ZVRA) Amortization of Deferred Charges (2014 - 2021)

Zevra Therapeutics' (ZVRA) quarterly Amortization of Deferred Charges came in at $118000.0 in Q1 2026, down 21.33% on a QoQ basis from $150000.0 in Q1 2021.

Analysis

Zevra Therapeutics (ZVRA) Amortization of Deferred Charges (2014 - 2021) Analysis & Trends

Zevra Therapeutics (ZVRA) has 9 years of Amortization of Deferred Charges data on file, last reported at $118000.0 in Q1 2026.

  • Quarterly Amortization of Deferred Charges changed N/A year-over-year to $118000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $118000.0 (changed N/A YoY) and the FY2025 annual result came in at $602000.0, up 9.06% from the prior year.
  • Amortization of Deferred Charges eased to $118000.0 in Q1 2026, from $150000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $118000.0 in Q1 2026 to a low of $118000.0 in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Zevra Therapeutics 734.60 Mn 513.03 Mn 38.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 150,000.00
Dec 31, 2020 582,000.00
Sep 30, 2020 578,000.00
Jun 30, 2020 574,000.00
Mar 31, 2020 571,000.00
Dec 31, 2019 675,000.00
Sep 30, 2019 371,000.00
Jun 30, 2019 305,000.00
Mar 31, 2019 305,000.00
Dec 31, 2018 512,000.00
Sep 30, 2018 326,000.00
Jun 30, 2018 390,000.00
Mar 31, 2018 1.03 Mn
Dec 31, 2017 390,000.00
Sep 30, 2017 391,000.00
Jun 30, 2017 390,000.00
Mar 31, 2017 1.03 Mn
Dec 31, 2016 391,000.00
Sep 30, 2016 390,000.00
Jun 30, 2016 393,000.00